Skip to main content
Number №3, 2025
First analysis of laboratory adherence in the Russian Federation to the sixth edition of the WHO laboratory manual for the examination and processing of human semen
Number №2, 2025
Post-Void Residual Urine Ratio (PVR-R) as a prognostic marker of chronic kidney disease in men with benign prostate hyperplasia
Number №1, 2025
The effect of testosterone replacement therapy on lower urinary tract symptoms (LUTS) in men
Number №4, 2024
The structure of damage of the genitourinary system in modern armed conflict
Number №3, 2024
Cost-effectiveness of urinary incontinence treatment in a short-stay hospital
Number №2, 2024
Complex medicines for correction of urine pH level during urolithiasis metaphylaxis
Number №1, 2024
Moscow program on histofusion biopsy of the prostate: results of a survey of practicing urologists based on data from a multicenter study
Number №4, 2023
Possibilities for improving the therapeutic activity of bacteriophage preparations Urological complications after renal transplantation
Number №3, 2023
Regulatory and legal possibilities for metaphylaxis of urolithiasis in the Russian Federation
Number №2, 2023
Frequency and nature of symptoms of dysfunction of the lower urinary tract in persons over 40 years old Postcoital cystitis as a cause of sexual dysfunction in women
Number №4, 2022
Surgical treatment of inferior vena cava tumor thrombus X-ray-free ureterolithotripsy for ureteral stones
Number №3, 2022
Brachytherapy for prostate cancer and immune response Risk factors for nephrolithiasis after radical cystectomy with intestinal plasty of the bladder
Number №2, 2022
The incidence of urolithiasis in the Russian Federation from 2005 to 2020 Urolithiasis and the risk of myocardial infarction and stroke
Number №1, 2022
A modern view on the screening of urolithiasis Hereditary factor of metaphylaxis of urolithiasis Treatment of infertility associated with a high level of sperm DNA fragmentation
Number №4, 2021
COVID-19 associated encrusting cystitis Endoscopic correction of vesicoureteral reflux in children: differentiated choice of method, material and dosage
Number №3, 2021
Artificial intelligence in urology oncology Mini-percutaneous nephrolithotomy without ureteral catheterization. Comparison with the standard method
Number №1, 2021
Epidemiological study of the prevalence of cystitis in women in the Voronezh region Congenital anomalies of the penis: world and domestic data
Number №5, 2020
Isolated kidney injury: international guidelines and Moscow standards
Number №3, 2020
Epidemiology of neurogenic urinary disorders. Treatment outcomes for high-risk prostate cancer patients: a multicenter analysis
Number №2, 2020
COVID-19: Impact on the Urological Service of the Russian Federation Genitourinary system and Covid-19: some aspects
Number №1, 2020
Distance education in urology. Experience 2012-2019 Inpatient care for urological patients in the context of the COVID-19 pandemic
Number №4, 2019
Male infertility in the Russian Federation: statistics for 2000-2018 Evaluation of the effectiveness of perineum muscle training in restoring erectile function
Number №3, 2019
Epidemiology of urolithiasis in the Perm region: results of a 30-year study The economic and economic rationale for the use of modern methods of treating urolithiasis
Номер №4, 2018
Incidence of ICD in the Russian Federation (2005-2016) Screening for prostate cancer: modern presentation and organization Primary multiple transitional cell epithelium Androgenic screening in men over 50 years
Номер №3, 2018
The role of stem cells in the treatment of urinary incontinence Percutaneous nephrolithotripsy in infected urine Testicular Prosthesis in Children and Adolescents: Results from a Multicenter Study Premature ejaculation is the current state of the problem.
Number №2, 2018
Alternative methods of treatment of localized prostate cancer Partial doubling of the urethra: paraurethral motion Comparative review of disposable flexible ureteronephroscope
Number №1, 2018
The prevalence of symptoms of impairment of the function of the lower urinary tract in men according to the results of a population study Patient-centered system of organization of medical care in urology using...
Number №4, 2017
Predicting the development of erectile dysfunction and cardiovascular diseases Prognostic factors of survival of patients with prostate cancer
Number №3, 2017
Recommendations for the treatment of prostate cancer with the help of high-power interstitial radiation therapy (brachytherapy)
Number №2, 2017

Radioisotope lymphoscintigraphy with PCa
Metabolic risk factors and formation of urinary stones
Ureteral amputation in the performance of contact ureterolithotrypsy

Number №1, 2017
Principles of «4P Medicine» in the organization of health care in the context of urological diseases Changes in the electrolyte composition of urine under the influence of sodium hypochlorite. The possibility of reducing the risk of recurrence of nephrolithiasis
Number №4, 2016
Preliminary results of a multicenter study of prostate cancer Analysis of specialized medical care for patients with gross hematuria, renal colic.
Number №3, 2016
Techniques for preserving continence after robot-prostatectomy The protective partial nephrectomy for renal cell carcinoma
Number №2, 2016
Медицинская помощь пациентам с острой задержкой мочеиспускания Прогностическое значение истинного кастрационного уровня тестостерона..
Number №1, 2016
The analysis of the accuracy of factors for the survival predictiry after radical cystectomy Citokine status in pathients with recurrent urinary tract infection
Number №4, 2015

Modern demographic situation in Russia Determination of gene mutations FGFR3 and PIK3CA DNA urine sediment from patients with bladder cancerя

Number №3, 2015
Neuroendocrine differentiation in cancer prostate. The role of viruses in carcinogenesis of bladder cancer.
Number №2, 2015
Clinical and economic evaluation of prostate cancer screening The combination RSAZ TMPRSS2-ERG in the diagnosis of prostate cancer: first experience
Number №1, 2015
The role of distance education in improving primary health care professionals. Comparative analysis of the results of cancer radical retropubic and robot-assisted prostatectomy.
Number №4, 2014
Experience of clinical and economical treatment cancer patients Comparison of analysis details for open, laparoscopic and robot-assisted nephrectomy in the..
Number №3, 2014
Medical and economic aspects of a comprehensive standardized program-stage diagnosis and treatment of benign prostatic hyperplasia
Number №2, 2014
Uronephrological morbidity and mortality in Russia in 2002-2012 Androgens and chronic ischemia PCA3 test-system: first results
Number №1, 2014
First results of standardized programme for BPH diagnosis and treatment Evaluation of serum Chromogranin A levels in different prostatic diseases Retarded ejaculation is a rare diagnosis
Number №4, 2013
Distance education in urology brachytherapy prostate cancer Erectile dysfunction and cardiovascular ...
Number №3, 2013
The incidence of kidney stones... HIFU-treatment of local recurrence of cancer... Non-prostatic sources of prostate...
Number №2, 2013
Risk factors for the development
of the urolithiasis in patients
with the metabolic syndrome
Number №1, 2013
Clinical and economic analysis of the surgical treatment of prostate cancer Brachytherapy prostate cancer: postimplantnaya dosimetry and dependence ... Simulation prostatic carcinogenesis
Number №4, 2012
Урологическая заболеваемость в Нижегородской области Стресс, метаболический синдром и хроническая болезнь почек TVT - 10 лет в России
Eksperimental'naya i klinicheskaya urologiya

Comparative analysis of the urethral and testicular microbiota in obstructive azoospermia patients with the results of assisted reproductive technologies

Number №3, 2025 - page 88-97
DOI: 10.29188/2222-8543-2025-18-3-88-97
For citation: Faniev M.V., Kadyrov Z.A., Prokopyev Ya.V., Fedorenko T.V., Markelova M.I., Khusnutdinova D.R., Grigorieva T.V. Comparative analysis of the urethral and testicular microbiota in obstructive azoospermia patients with the results of assisted reproductive technologies. Experimental and Clinical Urology 2025;18(3):88-97; https://doi.org/10.29188/2222-8543-2025-18-3-88-97
Faniev M.V. Kadyrov Z.A. Prokop'ev Ya.V. Fedorenko T.V. Markelova M.I. Husnutdinova D.R. Grigor'eva T.V.
Information about authors:
  • Faniev M.V. – PhD, Associate Professor of the department of endoscopic urology of faculty of continuous medical education of medical institute of RUDN University; Moscow, Russia; RSCI Author ID 1056145, https://orcid.org/0000-0002-7323-3126
  • Kadyrov Z.A. – Dr. Sci., professor, head of dept. of endoscopic urology, RUDN University; Moscow, Russia; RSCI Author ID 721133,https://orcid.org/0000-0002-1108-8138
  • Prokopyev Ya.V. – PhD, Associate Professor of the Department of Urology and Nephrology, Kazan State Medical Academy – branch of the Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation; Kazan, Russia; RSCI Author ID 1066425, https://orcid.org/0000-0002-4345-127X
  • Fedorenko T.V. – PhD, biologist, laboratory of cellular technologies, Center for Reproductive and Cellular Medicine, Diagnostic Center, Children's City Clinical Hospital of Krasnodar, Ministry of Health of Krasnodar region, Krasnodar, Russia; RSCI Author ID 706354,https://orcid.org/0009-0008-9780-4158
  • Markelova M.I. – Researcher, Scientific Research Laboratory «Multimix Technologies of Living Systems», Kazan Federal University, Institute of Fundamental Medicine and Biology; Kazan, Russia; RSCI Author ID 976359, https://orcid.org/0000-0001-7445-2091
  • Khusnutdinova D.R. – Chief Engineer of the Interdisciplinary Center for Proteomic Research, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia; RSCI Author ID 57188680130, https://orcid.org/0000-0002-9982-9059
  • Grigorieva T.V., PhD, Senior Researcher, OpenLab «Omics Technologies», Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia; Author ID 56310630200, https://orcid.org/0000-0001-5314-7012
293
Download PDF

Introduction. The problem of male infertility remains a pressing issue in the field of reproductive medicine, as male infertility progresses year after year. The male reproductive microbiome is a complex community of microorganisms that inhabit various parts of the male body, including the urethra, prostate, and seminal vesicles. Research shows that the microbiome plays an important role in maintaining reproductive health and may influence fertility.

Objective. To identify differences in the composition of the testicular and urethral microbiota between groups of patients with positive and negative results of assisted reproductive technologies (ART).

Materials and methods. A comparative analysis of the taxonomic structure of the testicular and urethral microbiota was conducted in 24 infertile men with obstructive azoospermia (OA) who underwent ART procedures. Pregnancy occurred in 13 cases (ART+ group), while pregnancy was not achieved in 11 cases (ARTgroup). To analyze the bacterial composition of the urogenital tract, biological material was collected from the urethra of all study participants, as well as a testicular biopsy. Analysis of bacterial 16S rRNA gene amplicons was performed using high-throughput next-generation sequencing (NGS). The obtained data were processed using QIIME software (version 1.9.1), which allowed for taxonomic analysis and assessment of microbiota diversity.

Results. Our study revealed significant differences in the microbiota composition between testicular and urethral tissue in infertile men with OA, as well as between groups of patients with positive and negative ART results. In testicular tissue, the main microbiota families were Enterobacteriaceae and Burkholderiaceae, while in the urethra, the dominant families were Mycobacteriaceae, Staphylococcaceae, Lactobacillaceae, and Peptoniphilaceae. Despite differences in microbiota composition, no significant differences in alpha diversity indices of testicular and urethral microbiota were found between the ARTand ART+ groups. However, in the ARTgroup, a significantly increased relative representation of 19 bacterial families was observed in the testicular microbiota compared to patients in the ART+ group, including increased representation of two families: Mycobacteriales and Legionellaceae. This may indicate a possible link between microbiota composition and ART success. Correlation analysis revealed a positive association between inhibin levels and testicular microbiota composition. This suggests that testicular microbiota may influence inhibin levels, which are an important marker of testicular function and may play a role in fertility.

Conclusions. The results demonstrate that OA-associated disorders lead to changes in the relative representation of individual families of the urethral and testicular microbiota, which has a significant impact on ART outcomes. The practical significance of these data is that microbiota correction may be a potential strategy for improving ART outcomes in patients with OA, opening up new approaches to treatment and enhancing fertility, and suggests the theory of «testicular fertility microbiota» and may subsequently play an important role in pre-conception cryopreservation in ART programs and the creation of new tests for sperm selection in artificial insemination programs.

Attachment Size
Download 2.23 MB
Keywords: microbiome; microbiota; azoospermia; male infertility; new generation sequencing (NGS); assisted reproductive technologies (ART)